Cerebroprotective effects of fixed-dose combination of perindopril arginine/ indapamide


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents a clinical case illustrating the improvement of cognitive functions, an increase in cerebral blood flow, a decrease in the left ventricular myocardial mass index against the background of treatment of a patient with a previously untreated uncomplicated hypertension with a fixed combination of an angiotensin-converting enzyme inhibitor perindopril arginine and a diuretic indapamide. The possibilities of antihypertensive therapy, in particular, the combination of perindopril with indapamide in the correction of cognitive impairments in arterial hypertension and their pathogenetic mechanisms are discussed.

Full Text

Restricted Access

About the authors

O. D Ostroumova

FSBEI HE MSMSU n.a. A.I. Evdokimov of RMH; FSAEI HE "First Moscow State Medical University n.a. I.M. Sechenov" of RMH

Email: ostroumova.olga@mail.ru
MD, Prof. at the Department of Faculty Therapy and Occupational Diseases; Prof. at the Department of Clinical Pharmacology and Propaedeutics of Internal Diseases Moscow

T. M Ostroumova

FSBEI HE MSMSU n.a. A.I. Evdokimov of RMH

Moscow

E. V Borisova

FSBEI HE MSMSU n.a. A.I. Evdokimov of RMH

Moscow

V. A Perepelov

FSBEI HE MSMSU n.a. A.I. Evdokimov of RMH

Moscow

References

  1. Диагностика и лечение артериальной гипертензии. Журнал «Системные гипертензии». 2010;3:5-26.
  2. Skoog I., Lernfelt B., Landahl S., et al. 15-years longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-45.
  3. Cacciatore F., Abete P., Ferrara N., et al. The role of blood pressure in cognitive impairment in an elderly population. J. Hypertens. 2002;15:0135-42.
  4. Elias P.K., D'Agostino R.B., Elias M.F., Wolf P.A. Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp. Aging. Res. 1995;21:393-417.
  5. Launer L.J., Masaki K., Petrovitch H., Foley D., Havlik R.J. The assotiation between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA. 1995;274:1846-51.
  6. Forette F., Seux M.-L., Staessen J.A., et al. for the Syst-Eur Investigators. The Prevention of Dementia with Antihypertensive Treatment. New evidence from the Systolic Hypertension (Syst-Eur) Study. Arch. Intern. Med. 2002;162(18):2046-52.
  7. Lithell H., Hansson L., Skoog I., Elmfeldt D., Hofman A., Olofsson B., Trenkwalder P., Zanchetti A., SCOPE Study Group. The study on cognition and prognosis in the elderly (SCOPE). Principal results of a randomised doubleblind intervention trial. J. Hypertens. 2003; 21:875-86.
  8. Tzourio C., Anderson C., Chapman N., Woodward M., Neal B., MacMahon S., Chalmers J. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch. Intern. Med. 2003;163(9): 1069-75.
  9. Marpillat N.L., Macquin-Mavier I., Tropeano A.-I., Bachoud-Levi A.-C., Maison P. Antihypertensive classes, cognitive decline andincidence of dementia: a networkmeta-analysis. J. Hypertens. 2013;31(6):1073-82.
  10. Mancia G., Fagard R., Narkiewicz K., Redon J., Zanchetti A., Bohm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., Galderisi M., Grobbee D.E., Jaarsma T., Kirchhof P., Kjeldsen S.E., Laurent S., Manolis A.J., Nilsson P.M., Ruilope L.M., Schmieder R.E., Sirnes P., Sleight P., Viigimaa M., Waeber B., Zannad F. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013;31:1281-357.
  11. Диагностика и лечение артериальной гипертонии: клинические рекомендации. Кардиол. вестник. 2015;X(1):3-30.
  12. Mogensen C.E., Viberti G., Halimi S., et al. Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes. Preterax in albuminuria regression: PREMIER. Hypertension. 2003;41:106371.
  13. Dahlof В., Gosse P., Gueret P., et al. Perindopril/ indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J. Hypertens. 2005;23:2063-70.
  14. Debbabi H., Bonnin P., Levy B. Effects of Blood Pressure Control With Perindopril/Indapamide on the Microcirculation in Hypertensive Patients. Am. J. Hypertension. 2010;23: 1136-43.
  15. Железных Е.А., Данилогорская Ю.А., Привалова Е.В., Беленков Ю.Н., Щендрыгина А.А., Павлов Н.А., Тишман М.И. Влияние комбинированной антигипертензивной тера пии индапамидом и периндоприлом на морфофункциональные параметры сердца, сосудов мелкого и среднего калибра и когнитивную функцию у пациентов с гипертонической болезнью. Кардиология. 2016;3:19-24.
  16. Остроумова О.Д., Резникова К.У. Когнитивные нарушения при артериальной гипертонии и возможности их коррекции. Врач. 2011;14:33-8.
  17. Пронин И.Н., Фадеева Л.М., Подопригора А.Е., Захарова Н.Е., Серков С.В., Родионов П.В., Шульц Е.И., Коршунов А.Е., Усачев Д.Ю., Лукшин В.А., Celik А., Потапов А.А., Корниенко В.Н. Спиновое маркирование артериальной крови (ASL) - метод визуализации и оценки мозгового кровотока. Лучевая диагностика и терапия. 2012;3(3): 64-78.
  18. Hajjar I., Zhao P., Alsop D., Novak V. Hypertension and Cerebral Vasoreactivity: A Continuous Arterial Spin Labeling MRI study. Hypertension. 2010;56(5):859-64.
  19. Wang T., Li Y., Guo X., Huang D., Ma L., Wang D.J., Lou X. Reduced perfusion in normal-appearing white matter in mild to moderate hypertension as revealed by 3D pseudocontinuous arterial spin labeling. J. Magn. Reson. Imaging. 2016;43(3):635-43.
  20. Tryambake D., He J., Firbank M.J., O'Brien J.T., Blamire A.M., Ford G.A. Intensive Blood Pressure Lowering Increases Cerebral Blood Flow in Older Subjects With Hypertension. Hypertension. 2013;61:1309-15.
  21. Жернакова Ю.В., Мычка В.Б., Чазова И.Е. Место комбинированной терапии в лечении больных с метаболическим синдромом. Кардиоваск. тер. и проф. 2010; 9(4):10-5.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies